As shown in Figure 1A, the expression of BMP9 in both superficial bladder cancer and infiltrating bladder cancer are higher than in the normal, healthy bladder, which suggests that the BMP9 may participate in the development and progression of bladder cancer. This evidence concerns the gene GDF2 and urinary bladder carcinoma.